These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 9017239

  • 21. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.
    Pollack AE, St Martin JL, MacPherson AT.
    Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284
    [Abstract] [Full Text] [Related]

  • 22. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ, Jasmin BJ, Chen JS, Iadarola MJ, St-Jean M, Wigle N, Blanchet P, Grondin R, Robertson GS.
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [Abstract] [Full Text] [Related]

  • 23. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA, Gerfen CR.
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [Abstract] [Full Text] [Related]

  • 24. Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C.
    Simpson CS, Morris BJ.
    Neuroscience; 1995 Sep; 68(1):97-106. PubMed ID: 7477939
    [Abstract] [Full Text] [Related]

  • 25. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE, Johnson KB, Jurevics HA, Criswell HE, Napier TC, Duncan GE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1454-63. PubMed ID: 1361576
    [Abstract] [Full Text] [Related]

  • 26. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
    Le Moine C, Svenningsson P, Fredholm BB, Bloch B.
    J Neurosci; 1997 Oct 15; 17(20):8038-48. PubMed ID: 9315922
    [Abstract] [Full Text] [Related]

  • 27. Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats.
    Guo X, Ding YM, Hu JY, Jin GZ.
    Life Sci; 1998 Oct 15; 62(25):2295-302. PubMed ID: 9651118
    [Abstract] [Full Text] [Related]

  • 28. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H, Kuroki T, Nakahara T, Hashimoto K, Tsutsumi T, Hirano M, Maeda H.
    Brain Res; 2007 Feb 02; 1131(1):88-96. PubMed ID: 17169339
    [Abstract] [Full Text] [Related]

  • 29. c-fos gene expression is induced in a subpopulation of striatal neurons following a single administration of a dopamine D1-receptor agonist in adult rats lesioned with 6-OHDA as neonates.
    Soghomonian JJ, Laprade N, Sandstrom M, Bruno JP.
    Brain Res Mol Brain Res; 1998 Jun 01; 57(1):155-60. PubMed ID: 9630593
    [Abstract] [Full Text] [Related]

  • 30. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 01; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 31. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 01; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 32. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG, Kobierski LA, Konradi C, Hyman SE.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9631-5. PubMed ID: 7937819
    [Abstract] [Full Text] [Related]

  • 33. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates.
    Sandstrom MI, Sarter M, Bruno JP.
    Brain Res Dev Brain Res; 1996 Oct 23; 96(1-2):148-58. PubMed ID: 8922677
    [Abstract] [Full Text] [Related]

  • 34. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
    Popoli P, Pèzzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L, Fuxe K, Ferré S.
    Neuropsychopharmacology; 2001 Oct 23; 25(4):505-13. PubMed ID: 11557164
    [Abstract] [Full Text] [Related]

  • 35. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul 23; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 36. Synergistic effect of D1 and D2 dopamine receptors on AP-1 DNA-binding activity in the striatum and globus pallidus of the rat with a unilateral 6-OHDA lesion of the medical forebrain bundle.
    Kashihara K, Akiyama K, Ishihara T, Shiro Y, Shohmori T.
    Life Sci; 1996 Jul 23; 59(20):1683-93. PubMed ID: 8890942
    [Abstract] [Full Text] [Related]

  • 37. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors.
    Keefe KA, Gerfen CR.
    J Comp Neurol; 1996 Apr 01; 367(2):165-76. PubMed ID: 8708002
    [Abstract] [Full Text] [Related]

  • 38. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
    Fenu S, Pinna A, Ongini E, Morelli M.
    Eur J Pharmacol; 1997 Feb 26; 321(2):143-7. PubMed ID: 9063681
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 26; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 40. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats.
    Drake JD, Kibuuka LN, Dimitrov KD, Pollack AE.
    Pharmacol Biochem Behav; 2013 Apr 26; 105():26-33. PubMed ID: 23369985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.